Medical device company Globus Medical reported a 115.9% YoY increase in quarterly revenue to $629.69m, surpassing analyst expectations.
Medical device company Globus Medical received positive coverage from research analysts, including BTIG Research, Barclays, Truist Financial, Stifel Nicolaus, and Morgan Stanley. These analysts increased their price targets for the company, with average ratings for the stock at Moderate Buy. Globus Medical reported a 115.9% YoY increase in quarterly revenue to $629.69m, surpassing analyst expectations of $615.33m. Institutional investors and hedge funds own 95.16% of the company's stock.
August 10, 2024
8 Articles